The global Animal Peptides Market is on a dynamic growth trajectory, projected to rise from USD 900.2 million in 2025 to USD 2,556.0 million by 2035, reflecting a robust CAGR of 11.0% over the next decade. This surge underscores the expanding role of animal-derived peptides across functional health, nutraceutical, and biopharmaceutical applications, positioning them as key ingredients in modern animal nutrition and therapeutic solutions.
Full Market Report available for delivery. For purchase or customization, please request here – https://www.futuremarketinsights.com/reports/sample/rep-gb-26121
Market Dynamics and Growth Drivers
The market’s initial phase (2025-2030) is expected to reach USD 1,518.6 million, accounting for nearly 38% of decade-long growth. This period will be characterized by widespread adoption in nutraceuticals, sports nutrition, and functional foods for livestock and companion animals. Collagen and milk-derived peptides are anticipated to dominate, benefiting from increased consumer awareness of bioactive properties and regulatory support for natural, clean-label formulations.
From 2030 to 2035, the market is projected to accelerate further, adding USD 1,037.4 million, driven by innovations such as precision hydrolysates, antimicrobial peptides, and advanced enzymatic processing technologies. By the decade’s end, animal peptides are expected to move beyond niche bioactive ingredients, becoming mainstream health solutions in both developed and emerging markets.
The rise of antibiotic-free animal nutrition and growing demand for sustainable, biologically effective alternatives have fueled the shift toward enzymatically derived peptides with immunomodulatory and antimicrobial properties. Peptides sourced from collagen, milk, and fish are increasingly recognized for benefits including joint mobility, gut health, and skin integrity in both pets and livestock.
Technological Innovations and Product Formats
Advancements in peptide extraction, microencapsulation, and recombinant fermentation have enhanced stability, bioavailability, and species-specific delivery. These technologies allow peptides to be seamlessly integrated into compound feeds, veterinary therapeutics, and premium pet nutraceuticals.
By form, powdered peptides dominate with a 58.3% share in 2025, owing to their versatility, shelf stability, and compatibility with premixes. Liquid concentrates and microencapsulated formats are gaining traction, particularly in veterinary therapeutics and performance animal feeds. Injectable peptides are emerging as high-value interventions for musculoskeletal, dermatological, and metabolic therapies in pets and livestock.
Leading Segments and Regional Insights
Collagen peptides are expected to lead the peptide type segment with 24.7% market share in 2025, primarily for joint, skin, and mobility-focused formulations. Fish-derived peptides and specialty bioactives are also gaining attention due to clean-label benefits and functional advantages. Poultry remains the largest species segment, accounting for 27.3% of revenue, followed by ruminants and swine. Companion animals are witnessing rapid growth due to the humanization of pet health, while aquaculture is emerging as a high-potential vertical.
Geographically, Asia-Pacific is leading expansion, with India projected at a CAGR of 13.4%, supported by industrialization in livestock and aquaculture, and growing pet health markets. China, at 11.4% CAGR, is witnessing strong adoption of antimicrobial and marine-derived peptides. Europe shows steady growth, with Germany and France integrating functional peptides in dairy, swine, and poultry applications, while the UK is seeing rising demand for cosmeceutical-grade pet formulations. North America, particularly the USA, is focused on therapeutic veterinary peptides and precision nutrition, while Brazil emerges as a key growth frontier in intensive livestock farming and aquaculture.
Competitive Landscape and Key Players
The Animal Peptides Market is moderately fragmented, featuring global leaders like PB Leiner, Gelita AG, Rousselot (Darling Ingredients), and Nitta Gelatin Inc., who leverage vertically integrated operations and global supply networks. Mid-sized firms such as Titan Biotech, Weishardt International, and NF Protein focus on feed-grade hydrolysates and specialty performance peptides, offering rapid formulation flexibility, especially in emerging markets.
Niche innovators like CPC Scientific, Bachem AG, and VPEP India Pvt. Ltd. are targeting therapeutic and research-grade peptides, emphasizing microencapsulation, injectable systems, and fermentation-based peptide expression. Strategic differentiation is increasingly tied to species-specific efficacy, bioavailability, and sustainability, with collaborations between veterinary networks, pet brands, and biotech firms driving value-added peptide solutions.
Key Developments
• PB Leiner: Recognized for its SOLUGEL® collagen peptides portfolio, derived from upcycled bovine, porcine, and fish sources. Certified grass-fed options cater to ethical sourcing and clean-label trends.
• Gelita AG: Developer of PETAGILE®, a bioactive collagen peptide ingredient for joint cartilage regeneration in companion animals, integrating functional feed lines to enhance digestibility and nutritional quality.
Stay Ahead with the Complete Market Analysis – Download Full Report: https://www.futuremarketinsights.com/reports/animal-peptides-market
Outlook
The Animal Peptides Market is transitioning from conventional hydrolysates to customized, clinically validated peptide solutions, reinforcing its role in sustainable, functional, and therapeutic animal nutrition. With rising innovation, expanding applications, and increasing regulatory support, both established and emerging players have significant opportunities to capitalize on this growth, driving the next decade of animal peptide advancements globally.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
